Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 8/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 8/20 | 0.49 |
| ▸ | SLC6A2 | P23975 | 6/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | CNR1 | P21554 | 1/20 | 0.49 |
| ▸ | HTR2A | P28223 | 1/20 | 0.49 |
| ▸ | HRH1 | P35367 | 1/20 | 0.49 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CTSK | P43235 | 1/20 | 0.39 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.37 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.37 |
| ▸ | CACNA1S | Q13698 | 1/20 | 0.37 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8028828 | 1.00 | SLC6A4 (0.49) | SLC6A4SLC6A3SLC6A2LMNACNR1 | |
| SCHEMBL8038699 | 1.00 | SLC6A4 (0.49) | SLC6A4SLC6A3SLC6A2LMNACNR1 | |
| SCHEMBL902642 | 0.84 | SLC6A2 (0.46) | SLC6A4SLC6A3SLC6A2LMNA | |
| SCHEMBL5379418 | 0.83 | ALDH1A1 (0.48) | SLC6A4SLC6A3SLC6A2LMNACNR1 | |
| SCHEMBL6328367 | 0.80 | SLC6A2 (0.51) | SLC6A4SLC6A3SLC6A2LMNACNR1 | |
| SCHEMBL8038690 | 0.79 | SLC6A4 (0.51) | SLC6A4SLC6A3SLC6A2LMNACNR1 | |
| SCHEMBL3347205 | 0.79 | SLC6A4 (0.51) | SLC6A4SLC6A3SLC6A2LMNACNR1 | |
| Hydrochloric Acid SCHEMBL3930855 | 0.78 | SLC6A4 (0.52) | SLC6A4SLC6A3SLC6A2LMNACNR1 | |
| SCHEMBL8040630 | 0.77 | SLC6A4 (0.49) | SLC6A4SLC6A3SLC6A2LMNACNR1 | |
| SCHEMBL2761798 | 0.77 | SLC6A2 (0.56) | SLC6A4SLC6A3SLC6A2LMNACNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1737473-A4 | LITHIUM COMBINATIONS, AND USES RELATED THERETO | NOVEN THERAPEUTICS LLC (US) | 2009-08-26 | — | — | EP | disclosed |
| WO-2008060397-A2 | METHOD OF TREATING THERMOREGULATORY DISFUNCTION | NOVEN THERAPEUTICS, LLC (US) | 2008-05-22 | — | — | WO | disclosed |
| EP-1893202-A2 | MULTIMEDIATOR DOPAMINE TRANSPORT INHIBITORS, AND USES RELATED THERETO | PREXA PHARMACEUTICALS, INC. (US) | 2008-03-05 | — | — | EP | disclosed |
| EP-1879574-A2 | MULTIMEDIATOR 5-HT6 RECEPTOR ANTAGONISTS, AND USES RELATED THERETO | PREXA PHARMACEUTICALS, INC. (US) | 2008-01-23 | — | — | EP | disclosed |
| EP-1737473-A2 | LITHIUM COMBINATIONS, AND USES RELATED THERETO | Satow, Philip, Maxwell (US) | 2007-01-03 | — | — | EP | disclosed |
| WO-2006091702-A2 | MULTIMEDIATOR DOPAMINE TRANSPORT INHIBITORS, AND USES RELATED THERETO | PSYCHENOMICS, INC. (US) | 2006-08-31 | — | — | WO | disclosed |
| WO-2006091703-A2 | MULTIMEDIATOR 5-HT6 RECEPTOR ANTAGONISTS, AND USES RELATED THERETO | PSYCHENOMICS, INC. (US) | 2006-08-31 | — | — | WO | disclosed |
| WO-2005102366-A2 | LITHIUM COMBINATIONS, AND USES RELATED THERETO | SATOW PHILIP MAXWELL (US) | 2005-11-03 | — | — | WO | disclosed |
| EP-1165487-A1 | DERIVATIVES OF VENLAFAXINE AND METHODS OF PREPARING AND USING THE SAME | Sepracor Inc. (US) | 2002-01-02 | — | — | EP | disclosed |
| EP-1135359-A1 | DERIVATIVES OF (-)-VENLAFAXINE AND METHODS OF PREPARING AND USING THE SAME | Sepracor Inc. (US) | 2001-09-26 | — | — | EP | disclosed |
| EP-1135358-A1 | DERIVATIVES OF (+)-VENLAFAXINE AND METHODS OF PREPARING AND USING THE SAME | Sepracor Inc. (US) | 2001-09-26 | — | — | EP | disclosed |
| WO-2000076956-A2 | ENANTIOMERS OF N-DESMETHYL VENLAFAXINE | AMERICAN HOME PRODUCTS CORPORATION (US) | 2000-12-21 | — | — | WO | disclosed |
| WO-2000059851-A1 | DERIVATIVES OF VENLAFAXINE AND METHODS OF PREPARING AND USING THE SAME | SEPRACOR INC. (US) | 2000-10-12 | — | — | WO | disclosed |
| WO-2000032556-A1 | DERIVATIVES OF (-)-VENLAFAXINE AND METHODS OF PREPARING AND USING THE SAME | SEPRACOR INC. (US) | 2000-06-08 | — | — | WO | disclosed |
| WO-2000032555-A1 | DERIVATIVES OF (+)-VENLAFAXINE AND METHODS OF PREPARING AND USING THE SAME | SEPRACOR INC. (US) | 2000-06-08 | — | — | WO | disclosed |